QCast Episode 67: The Analysis of Direct and Indirect Pathways in Observational Studies
In this episode, Jullia and Tom discuss direct and indirect pathways in observational studies, focusing on mediation analysis and what it can and cannot show.
Learn more
QCast Episode 66: What is Clinical Traceability?
In this episode, Jullia and Tom discuss the challenges of clinical traceability when studies involve multiple systems, CROs, labs, and technology providers.
Learn more
QCast Episode 65: Clinical Trial Trends Shaping Modern Drug Development
In this episode, Jullia and Tom discuss how recent clinical trial trends are changing practical decisions for sponsors and CROs.
Learn more
QCast Episode 64: Tipping Point Analysis in Clinical Trials
In this episode, Jullia and Tom discuss how tipping point analysis helps teams understand how strongly a study conclusion depends on missing data assumptions.
Learn more
QCast Episode 63: Audit Trail Review in Clinical Trials
In this episode, Jullia and Tom discuss how teams decide what to review, how risk shapes scope, and where clinical judgement is needed for interpretation.
Learn more
QCast Episode 62: Drug Adherence and Persistence
In this episode, Jullia and Tom explain how adherence differs from persistence, what prescribing and dispensing data shows, and how thresholds shape findings.
Learn more
QCast Episode 61: The Role of Data Monitoring Committees (DMC) in Clinical Trials
In this episode, Jullia and Tom explain how DMCs support participant safety and trial integrity, and why confidential interim data needs careful handling.
Learn more
QCast Episode 60: Oncology Phase 1 Trial Design
In this episode, Jullia and Tom discuss how oncology Phase 1 trial design has moved beyond simply identifying the maximum tolerated dose.
Learn more
QCast Episode 59: Clinical Data Quality
In this episode, Jullia and Tom look at how clinical data quality is shaped from study set-up through collection, review and integration.
Learn more
QCast Episode 58: Rescue Studies
In this episode, Jullia and Tom discuss how to assess a study in difficulty, handle existing data, manage handovers, and set expectations for recovery.
Learn more
.png?width=110&name=ACDM_Corporate_Member_Badge_135%20(3).png){kind=icon}
.png?width=140&name=cdisc_gold_partner_80h%20(2).png)
